1. 45P The RevCAR T cell platform: A switchable and combinatorial therapeutic strategy for glioblastoma. (December 2022) Authors: Mitwasi, N.; Hassan, H.; Arndt, C.; Loureiro, L.; Neuber, C.; Kegler, A.; Kubeil, M.; Toussaint, M.; Deuther-Conrad, W.; Bachmann, M.; Feldmann, A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗